Smith & Nephew SNATS PE Ratio 2010-2024 | SNN
Current and historical p/e ratio for Smith & Nephew SNATS (SNN) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Smith & Nephew SNATS PE ratio as of June 18, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Smith & Nephew SNATS PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-18 | 28.58 | 0.00 | |
| 2024-12-31 | 24.18 | 0 | 0.00 |
| 2024-06-30 | 24.14 | 0 | 0.00 |
| 2023-12-31 | 26.08 | 0 | 0.00 |
| 2023-06-30 | 30.46 | 0 | 0.00 |
| 2022-12-31 | 24.97 | 0 | 0.00 |
| 2022-06-30 | 25.60 | 0 | 0.00 |
| 2021-12-31 | 31.29 | 0 | 0.00 |
| 2021-06-30 | 38.94 | 0 | 0.00 |
| 2020-12-31 | 37.35 | 0 | 0.00 |
| 2020-06-30 | 33.51 | 0 | 0.00 |
| 2019-12-31 | 41.68 | 0 | 0.00 |
| 2019-06-30 | 37.51 | 0 | 0.00 |
| 2018-12-31 | 31.85 | 0 | 0.00 |
| 2018-06-30 | 31.74 | 0 | 0.00 |
| 2017-12-31 | 29.25 | 0 | 0.00 |
| 2017-06-30 | 28.92 | 0 | 0.00 |
| 2016-12-31 | 24.67 | $0.36 | 68.53 |
| 2015-12-31 | 28.66 | $0.59 | 48.58 |
| 2015-06-30 | 27.15 | $0.79 | 34.37 |
| 2014-12-31 | 29.07 | $1.13 | 25.82 |
| 2014-09-30 | 26.46 | $1.13 | 23.50 |
| 2014-06-30 | 28.06 | $1.16 | 24.11 |
| 2014-03-31 | 23.76 | $1.25 | 19.04 |
| 2013-12-31 | 22.29 | $1.23 | 18.15 |
| 2013-09-30 | 19.22 | $1.18 | 16.24 |
| 2013-06-30 | 17.27 | $1.22 | 14.21 |
| 2013-03-31 | 17.53 | $1.59 | 11.04 |
| 2012-12-31 | 16.82 | $1.63 | 10.31 |
| 2012-09-30 | 16.58 | $1.63 | 10.18 |
| 2012-06-30 | 15.04 | $1.63 | 9.24 |
| 2012-03-31 | 15.02 | $1.31 | 11.45 |
| 2011-12-31 | 14.33 | $1.30 | 11.02 |
| 2011-09-30 | 13.20 | $1.40 | 9.45 |
| 2011-06-30 | 16.00 | $1.40 | 11.46 |
| 2011-03-31 | 16.51 | $1.36 | 12.11 |
| 2010-12-31 | 15.38 | $1.38 | 11.18 |
| 2010-09-30 | 13.20 | $1.26 | 10.51 |
| 2010-06-30 | 13.67 | $1.24 | 10.99 |
| 2010-03-31 | 14.44 | $1.20 | 11.99 |
| 2009-12-31 | 14.78 | $1.06 | 13.89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $12.517B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.372B | 27.70 |
| Boston Scientific (BSX) | United States | $149.971B | 37.54 |
| Stryker (SYK) | United States | $142.469B | 29.79 |
| EssilorLuxottica (ESLOY) | France | $128.310B | 0.00 |
| Medtronic (MDT) | Ireland | $109.952B | 15.59 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.265B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.015B | 26.80 |
| ResMed (RMD) | United States | $36.786B | 27.63 |
| GE HealthCare Technologies (GEHC) | United States | $32.917B | 15.63 |
| Agilent Technologies (A) | United States | $32.815B | 21.39 |
| Terumo (TRUMY) | Japan | $26.606B | 34.56 |
| Koninklijke Philips (PHG) | Netherlands | $21.242B | 14.90 |
| Insulet (PODD) | United States | $21.238B | 83.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.915B | 11.51 |
| Baxter (BAX) | United States | $15.293B | 11.42 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.087B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.313B | 21.97 |
| Lantheus Holdings (LNTH) | United States | $5.465B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.133B | 18.46 |
| Perrigo (PRGO) | Ireland | $3.618B | 9.17 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.366B | 15.33 |
| ICU Medical (ICUI) | United States | $3.165B | 23.34 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.916B | 13.18 |
| LeMaitre Vascular (LMAT) | United States | $1.846B | 41.26 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.335B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.144B | 11.62 |
| Neogen (NEOG) | United States | $1.083B | 13.86 |
| Green Thumb Industries (GTBIF) | United States | $1.059B | 23.81 |
| BioLife Solutions (BLFS) | United States | $1.022B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.971B | 12.41 |
| InMode (INMD) | Israel | $0.843B | 8.50 |
| Kestra Medical Technologies (KMTS) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.643B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.547B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.545B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.512B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.386B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.282B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.263B | 78.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.93 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| Quanterix (QTRX) | United States | $0.248B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.245B | 0.00 |
| ZimVie (ZIMV) | United States | $0.240B | 10.90 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.236B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.15 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.76 |
| Jin Medical (ZJYL) | China | $0.110B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.25 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.076B | 0.00 | |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |